Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 26 , ISSUE 3 ( March, 2022 ) > List of Articles

LETTER TO THE EDITOR

Corticosteroids for Non-severe COVID-19: Primum Non Nocere

Valliappan Muthu, Inderpaul S Sehgal, Sahajal Dhooria, Kuruswamy Thurai Prasad, Ashutosh N Aggarwal, Ritesh Agarwal

Keywords : Acute respiratory distress syndrome, Corticosteroids, COVID-19

Citation Information : Muthu V, Sehgal IS, Dhooria S, Prasad KT, Aggarwal AN, Agarwal R. Corticosteroids for Non-severe COVID-19: Primum Non Nocere. Indian J Crit Care Med 2022; 26 (3):403-404.

DOI: 10.5005/jp-journals-10071-24138

License: CC BY-NC 4.0

Published Online: 30-03-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

HTML PDF Share
  1. Nasa P, Chaudhry D, Govil D, Daga MK, Jain R, Chhallani AA, et al. Expert consensus statements on the use of corticosteroids in non-severe COVID-19. Indian J Crit Care Med 2021;25(11):1280–1285. DOI: 10.5005/jp-journals-10071-23923.
  2. Rochwerg B, Agarwal A, Siemieniuk RA, Agoritsas T, Lamontagne F, Askie L, et al. A living WHO guideline on drugs for covid-19. British Medical Journal 2020;370:m3379. DOI: 10.1136/bmj.m3379.
  3. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021;384(8):693–704. DOI: 10.1056/NEJMoa2021436.
  4. Garg M, Prabhakar N, Bhalla AS, Irodi A, Sehgal I, Debi U, et al. Computed tomography chest in COVID-19: when and why? Indian J Med Res 2021;153(1):86–92. DOI: 10.4103/ijmr.IJMR_3669_20.
  5. Garg D, Muthu V, Sehgal IS, Ramachandran R, Kaur H, Bhalla A, et al. Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia 2021;186(2):289–298. DOI: 10.1007/s11046-021-00528-2.
  6. Muthu V, Rudramurthy SM, Chakrabarti A, Agarwal R. Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world. Mycopathologia 2021;186(6):739–754. DOI: 10.1007/s11046-021-00584-8.
  7. Patel A, Agarwal R, Rudramurthy SM, Shevkani M, Xess I, Sharma R, et al. Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India. Emerg Infect Dis 2021;27(9): 2349–2359. DOI: 10.3201/eid2709.210934.
  8. Waljee AK, Rogers MA, Lin P, Singal AG, Stein JD, Marks RM, et al. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. British Medical Journal 2017;357:j1415. DOI: 10.1136/bmj.j1415.
  9. Shuto H, Komiya K, Yamasue M, Uchida S, Ogura T, Mukae H, et al. A systematic review of corticosteroid treatment for noncritically ill patients with COVID-19. Sci Rep 2020;10(1):20935. DOI: 10.1038/s41598-020-78054-2.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.